Scancell Holdings plc
SCNLF · OTC
4/30/2025 | 4/30/2024 | 4/30/2023 | 4/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.12 | 0.15 | -0.07 | 0.13 |
| FCF Yield | -5.19% | -16.39% | -5.80% | -42.42% |
| EV / EBITDA | -8.48 | -8.34 | -11.76 | 0.52 |
| Quality | ||||
| ROIC | -144.56% | -51.75% | -41.10% | -26.77% |
| Gross Margin | 94.95% | 90.04% | 90.04% | 0.00% |
| Cash Conversion Ratio | 0.52 | 1.72 | 0.57 | 1.24 |
| Growth | ||||
| Revenue 3-Year CAGR | -3.67% | – | – | – |
| Free Cash Flow Growth | 59.51% | -89.82% | 2.39% | -78.10% |
| Safety | ||||
| Net Debt / EBITDA | 0.04 | -0.41 | 0.03 | 5.88 |
| Interest Coverage | -10.86 | -10.95 | -9.81 | -4.61 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | -9.37 |
| Cash Conversion Cycle | -929.37 | -610.93 | -910.07 | -1,093.03 |